June 24, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Deanna Virginio
Re: | Elevation Oncology, Inc. |
Registration Statement on Form S-1 | |
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 500 copies of the Preliminary Prospectus dated June 21, 2021 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:30 p.m. Eastern Time, on June 24, 2021 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours, | ||
J.P. MORGAN SECURITIES LLC | ||
JEFFERIES LLC | ||
SVB LEERINK LLC | ||
As representatives of the Underwriters | ||
J.P. MORGAN SECURITIES LLC | ||
By: | /s/ David Ke | |
Name: David Ke | ||
Title: Managing Director | ||
COWEN AND COMPANY, LLC | ||
By: | /s/ Bill Follis | |
Name: Bill Follis | ||
Title: Managing Director | ||
SVB LEERINK LLC | ||
By: | /s/ Stuart Nayman | |
Name: Stuart Nayman | ||
Title: Managing Director, Senior Legal Counsel |
[Signature Page to Elevation Oncology, Inc. Acceleration Request]